Sarepta Therapeutics
SRPT
SRPT
402 hedge funds and large institutions have $9.38B invested in Sarepta Therapeutics in 2023 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 150 increasing their positions, 125 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
24% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 78
31% less call options, than puts
Call options by funds: $276M | Put options by funds: $402M
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Holders
402
Holding in Top 10
7
Calls
$276M
Puts
$402M
Top Buyers
| 1 | +$112M | |
| 2 | +$106M | |
| 3 | +$80.3M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$75.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$73M |
Top Sellers
| 1 | -$121M | |
| 2 | -$96.3M | |
| 3 | -$66.1M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$59.2M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$51.1M |